Table 5 Comparison of different variables in T1a and T1b stages
Variables | T1a stage | T1b stage | Total | p |
|---|---|---|---|---|
n (%) | n (%) | n (%) | ||
Age (years) | 0.087 | |||
≤ 59 | 3 (42.9%) | 4 (57.1%) | 7 (5.8%) | |
60–69 | 27 (61.4%) | 17 (38.6%) | 44 (36.7%) | |
70–79 | 22 (48.9%) | 23 (51.1%) | 45 (37.5) | |
≥ 80 | 7 (29.2%) | 17 (70.8%) | 24 (20.0%) | |
PSA (ng/mL) | 0.041 | |||
0.00–0.99 | 8 (50.0%) | 8 (50.0%) | 16 (13.3%) | |
1.00–2.49 | 27 (62.8%) | 16 (37.2%) | 43 (35.8%) | |
2.50–3.99 | 9 (60.0%) | 6 (40.0%) | 15 (12.5%) | |
4.00–9.99 | 12 (37.5%) | 20 (62.5%) | 32 (26.7%) | |
≥ 10.00 | 3 (21.4%) | 11 (78.6%) | 14 (11.7%) | |
Gleason grade group | 0.0001 | |||
Group 1 | 49 (73.1%) | 18 (26.9%) | 67 (55.8%) | |
Group 2 | 5 (50.0%) | 5 (50.0%) | 10 (8.3%) | |
Group 3 | 2 (40.0%) | 3 (60.0%) | 5 (4.2%) | |
Group 4 | 1 (7.1%) | 13 (92.9%) | 14 (11.7%) | |
Group 5 | 2 (8.3%) | 22 (91.7%) | 24 (20.0%) | |
Perineural invasion | 0.0001 | |||
Positive | 1 (4.4%) | 22 (95.6%) | 23 (19.2%) | |
Negative | 58 (59.8%) | 39 (40.2%) | 97 (80.8%) | |
Lymphovascular invasion | 0.0001 | |||
Positive | 0 (0.0%) | 9 (100.0%) | 9 (7.5%) | |
Negative | 59 (53.2%) | 52 (46.8%) | 111 (92.5%) | |
Total | 59 (49.2%) | 61 (50.8%) | 120 (100.0%) |